ELI-008

N/A

Report date: 2023/11/06 14:34:48

Base Information

Drug NameELI-008
Drug Alias NameInvestigational p53 hotspot mutation-peptide vaccineELI-008
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulantsTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesElicio Therapeutics
Inactive CompaniesN/A
Active IndicationsGastrointestinal Stromal Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A